Connect with us

Women’s Health

Dobbs v. Jackson Women’s Health Abortion Case, Explained

Published

on

After months of deliberation, the Supreme Court announced that it would hear a case on a 15-week abortion ban in Mississippi this fall. In this case, the court – made up of a 6-3 anti-abortion majority, including three people appointed by Donald Trump – has the potential to facilitate, if not set the Roe v precedent, legal access to abortions across the country. Wade to fully undo.

Dobbs v. Jackson Women’s Health is focused on a Mississippi law that bans abortions after 15 weeks – before some people even know they are pregnant and before many of the most serious fetal diagnoses can be made, though the law claims to provide exemptions in those cases . Even people who know they are pregnant and have decided to have an abortion may have difficulty doing it before week 15 as many face limitations and obstacles that further delay access to the procedure, including the Costs for travel, accommodation and child care.

As the first major case in the Supreme Court since Judge Amy Coney Barrett joined the bank last fall, Dobbs raises many questions about the future of legal abortion care in the US and how to support access to abortion regardless of the outcome. Here’s what we know so far.

What does Dobbs v. Jackson at stake?

Dobbs v. Jackson Women’s Health emerges from a Mississippi 2018 bill that bans abortion after 15 weeks and focuses on “whether any pre-viable abortion bans are unconstitutional”. Pregnancy restrictions before abortion are viable include any laws that prohibit abortion before the fetus is viable outside the uterus, which is usually between 24 and 28 weeks. Because of the Roe v. Wade’s 1973 standards make abortion bans before viability unconstitutional. The 15-week Mississippi ban in question has faced legal challenges since 2018, and even a conservative federal appeals court overturned it in 2019 in compliance with the pre-viability standard.

Despite the appeals court’s 2019 ruling, the Supreme Court and its anti-abortion majority stand a chance not only to uphold the 15-week abortion ban, but also to reverse the viability standard and even widen Roe. This would leave the right to abortion to states – a dangerous scenario as most states do not include the right to abortion in their state constitutions and some even have trigger laws that would automatically ban abortions if or when Roe is reversed.

With Dobbs, the court could also set the precedent of Planned Parenthood v. Casey, a 1992 decision that upheld Roe stating that abortion restrictions do not undermine an undue burden on a person’s ability to have an abortion performed. But while the Planned Parenthood case upheld legal abortion, it also helped make more abortion laws and Supreme Court cases like this possible due to the ambiguity of the “undue burden” standard.

The judges could back up Roe in words to present the image of respect for precedents while still decimating access to abortion – a growing trend, especially in the last 10 years when more than a third of the roughly 1,200 state abortion restrictions were enacted. About 90 percent of U.S. counties do not have an abortion provider. Even if the Supreme Court lifts Mississippi’s 15-week ban, as Medical Services ruled against Russo in June last year, which focused on laws to shut down clinics in Louisiana, the court can say it is ready to go ahead Hear cases on other abortion restrictions.

At best, the court could impose this 15-week abortion ban and all other abortion bans, and reiterate the Planned Parenthood vs. Casey standard that restrictions on abortion must not create undue burdens on access. But considering that six of the nine judges have long denied abortion rights, this is unlikely.

How could Dobbs affect access to abortion in the US?

Depending on how the court decides, more abortion bans and restrictions could be passed – and there are already many. In May, Texas Governor Greg Abbott signed a bill that not only bans abortion after six weeks, but also gives any U.S. citizen the power to sue someone who performs an abortion, or who helped or who had an abortion helped. In April, states signed Law 28 Restrictions on Abortion in One Week – the most for a week in recent history, making 2021 one of the most dangerous years for abortion rights.

Over the past year, the COVID-19 pandemic has also had a major impact on access to abortion, giving states a lot of leeway at one point to ban abortions by classifying them as “non-essential health care.” Additionally, the pandemic has created many travel, cost, and safety barriers as COVID cases and deaths have skyrocketed, as have unemployment and the loss of health insurance. As a result, more and more people began using abortion drugs that are safe to take at home, but many states and the Trump administration worked quickly to restrict this form of abortion care. The Dobbs case could, by and large, further reinforce restrictions on drug abortion and abortion care, by changing what Roe v. Wade’s protective measures should be lifted – it was only in January that the court dealt a heavy blow to access to drug abortions.

The health, economic and safety effects of limited access to abortion can be incredibly damaging. Research has shown that inability to have an abortion can drive someone into poverty, worsen their physical and mental health, or increase the likelihood of remaining in an abusive relationship. We also know that states with stronger abortion restrictions tend to have higher maternal mortality rates and that women of color are more likely to die from pregnancy or childbirth complications.

How can we support safe access to abortion regardless of how the court decides?

Dobbs v. Jackson Women’s Health is an incredibly high risk case, but it’s important to remember that the right to abortion has always been under threat, and abortion providers and advocates have always helped people get the care they were looking for, regardless.

If the worst-case scenarios for access to abortion become a reality, it doesn’t mean the battle is over. Elections – especially at the state and local levels – have always been of great importance to reproductive rights, and will be even more so if Roe is overthrown or if states are given a free hand to enact other abortion bans like Mississippi’s. That means that each of us must double up and research our state lawmakers and make sure we vote and organize for local officials who oppose abortion bans and work to expand access to abortion. Thankfully, groups like #VOTEPROCHOICE and local NARAL and Planned Parenthood chapters make this a lot easier with their comprehensive voter guides.

And of course, at the federal level, it’s important to listen to advocates of reproductive rights and justice, not the anti-abortion politicians who have spent their careers ending legal abortions just to gaslighten us and their selections for judges to claim and judges will uphold Roe’s precedent.

Elections are important, but there is no substitute for direct community support. Local abortion funds provide direct financial support for the cost of abortion and the associated costs of transportation, housing, childcare, and more, and have always been vital as federal and many federal laws prohibit public funding of abortion care. Abortion funds exist and have connected people with the care they need since abortion was legal. Finding, donating to, and volunteering with your local abortion fund or a fund in a region with significant supply barriers can help facilitate safe access to abortions, regardless of how the Supreme Court rules.

As with any high profile, abortion-related Supreme Court case or draconian abortion laws, we must remain vigilant and be aware of the threat Dobbs poses to Jackson Women’s Health. But it’s also important to stay motivated and forceful to continue the struggle beyond any individual decision or choice, and to do the work in our communities to ensure that each of us receives the care we need, regardless of the political attacks we face.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Women’s Health

Organon announces commitment to accelerating advancements in women’s health at EXPO 2020

Published

on

With a diverse portfolio that includes women’s health, biosimilars and established brands, Organon is the only company in the world that is solely focused on women’s health. Serving 140 markets with 60 drugs and solutions, the healthcare company now operates in the United Arab Emirates, Oman, Kuwait, Qatar, KSA, Egypt, Lebanon, Jordan, Turkey and Ukraine. In line with the UN Sustainable Development Goal for Gender Equality and the Empowerment of Women, Organon’s mission is to improve and innovate health care for women.

Comment on the start, Ramy Koussa, Vice President of Organon MENAT, said: “Our goal is to advance health care for women in MENAT by addressing their unmet needs and helping to build a healthier and better future for all women, families and communities With local authorities and industry stakeholders, we seek to shift the paradigm of women’s health beyond reproductive health and embrace the full life cycle. This forum is an important first for us at Organon MENAT to listen to women and become a trusted partner in the health care of women in the region, “he added.

Topics discussed by the respected women’s health experts included existing data gaps hindering improvements in women’s health, monitoring progress towards the UN Sustainable Development Goal of gender equality, investing in health care and accelerating change through economic growth Strengthening. Panelists present included: Dr Susanne Fiedler, Chief Commercial Officer of Organon; Susanne Michail, Regional Director of the United Nations Unit for Gender Equality and Women’s Empowerment in Arab States; Bathylle Missika, Head of Networks, Partnerships and Gender at the OECD Development Center; Myra Betron, Director of Gender Issues at Jhpeigo; and Dina El– Shenoufy, Chief Investment Officer at Flat6lab.

MS. Susanne Michail, Regional Director of the United Nations Unit for Gender Equality and Women’s Empowerment in Arab States, said: “A better understanding and better management of the unmet health needs of women is essential for achieving the sustainable goals of the 2030 Agenda, including the extremely important gender equality and economic empowerment goals for women. In addition to considering health services as a fundamental right per se, women’s health is also directly related to economic development. For example, women could add $ 28 trillion (or 26% of global GDP) of the world economy by 2025 when their health issues are addressed so they can better participate in the labor market. So it is exciting to see how Organon is focusing on the health needs of women and accelerating advances in women’s health in the region. “

Commentary after the panel discussion, Dr Susanne Fiedler, Organon’s Chief Commercial Officer, said, “At Organon we are working towards a world where every woman can enjoy better health. To this end, we will work closely with industry stakeholders, from private to public organizations, health care providers, Patient societies and others to develop efficient and differentiated operating models to improve the delivery of health services to women across the region. ”

DR Sawsan AS Al Madhi, Director General, Friends of Cancer Patients, added, “Friends of Cancer Patients (FOCP) is a patient-centric organization. We fundamentally believe that the patient must be heard and empowered to ensure the best possible care. We welcome the introduction of Organon across the board middle East, North africa and Turkey Region and look forward to our collaborative approach to better understand and address the unmet health needs of women. “

With a dynamic business model and entrepreneurial approach, and in line with its commitment to accelerating progress in women’s health, the company also launched the Femtech Accelerator Program in the middle East and North africa together with the early-stage venture capital firm Flat6Labs, the result of their first official regional collaboration. Together, the companies will support women-led and focused start-ups in the digital healthcare sector and help them develop a Medium Viable Product (MVP). Selected start-ups take part in a two-month intensive acceleration program with individual coaching and mentoring with relevant leading industry experts, online training and matchmaking with potential technology, investment and business partners.

Copyright © 2021 Organon Group of Companies. All rights reserved. If you need an update, have an inquiry or need to report a side effect, you can contact the following address:

Tel .: +9714 5639700
Fax: +9714 5805629
E-mail: [email protected]

About Organon:

Organon (NYSE: OGN) is a global healthcare company that emerged from a spin-off from Merck and known outside the United States as MSD The United States and Canadato focus on improving women’s health throughout their lives. For your health, the company has a portfolio of more than 60 drugs and products from a number of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and a stable franchise of established drugs, Organon’s products generate strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to work with biopharmaceutical innovators who wish to commercialize their products by leveraging their size and presence in rapidly growing international markets.

Organon has a global presence of significant size and geographic reach, world class commercial capabilities, and approximately 9,000 employees headquartered in Jersey City, New Jersey.

For more information, visit www.organon.com and connect with us on LinkedIn, Instagram and Facebook.

Photo – https://mma.prnewswire.com/media/1671656/Organon.jpg
Logo – https://mma.prnewswire.com/media/1671657/Organon_Logo.jpg

SOURCE Organon

similar links

https://www.organon.com

Continue Reading

Women’s Health

FIGO 2021 World Congress Blog – Day Five

Published

on

Investigation of Controversies in Treatment at the Israel Forum

The fifth day of the FIGO 2021 World Congress began with a session on treatment controversies, which took place live on the Israel Forum and was streamed directly on our virtual platform. During that session there was a fascinating debate about the use of valaciclovir to prevent vertical transmission of cytomegalovirus. Dr. Yacov Amir spoke first, suggesting that valaciclovir was an effective form of treatment, followed by Dr. Rinat Gabbay-Benziv, who argued that it had its limits. The session ended with a panel discussion and questions and answers between the speakers and moderators.

COVID-19 and the women’s health crisis

We then had the honor of enjoying the BN Purandare lecture organized by the Federation of Obstetric and Gynecological Societies of India (FOGSI). Dr. Alpesh Gandhi gave a keynote on the “Women’s Health Crisis During the COVID-19 Pandemic”.

In his lecture, Dr. Gandhi provided a comprehensive look at the many impacts of the pandemic on women’s health, including an increase in maternal mortality, limited access to family planning and abortion services, delays in gynecological surgeries, and a lack of access to COVID vaccinations for pregnant women. He stressed that the pandemic had resulted in women avoiding health facilities and highlighted the essential role of community health workers, midwives and telemedicine in addressing this challenge.

Learn more about FIGO’s pen surgery training initiative

Following this, the FIGO Committee for Fistulas and Genital Trauma organized a meeting on the FIGO Fistula Surgery training initiative. Gillian Slinger, Senior Project Manager of the FIGO initiative, started the session with an update on the initiative’s recent successes and future plans to expand the training program. Dr. Fekade Aneyachew Aklilu described the role of trainers in delivering fistula surgery training in resource-poor environments and the challenges one faces in becoming a trainer.

Dr. Hillary Mabeya then gave a presentation of advice for aspiring fistula surgery trainees and gave an insight into what to expect when training to become a fistula surgeon. Dr. Andrew Browning closed the session with a talk on persistent incontinence after fistula repair – with an emphasis on diagnosis, management and corrective surgery.

The meeting was rounded off by a discussion between Ms. Slinger and Dr. Mabeya on the importance of continuous training, the essential role of working with larger teams beyond surgeons, and the role FIGO has played in eradicating fistulas around the world.

Prenatal diagnostics

Later, the FIGO Maternal and Fetal Health Track organized a session on prenatal diagnostics. We first heard from Professor Lyn Chitty who gave a talk on rapid fetal exome sequencing for the diagnosis of monogenic conditions in fetuses with structural abnormalities. She focused on explaining what rapid fetal exome sequencing is, what it will deliver, and provided an overview of how it is currently being used in the UK NHS. Professor Svetlana Rechitsky focused on pre-implantation genetic testing (PGT-A) with Embryo Selection, in particular on the management of mosaic embryos.

Dr. James Goldberg spoke about advanced pre-conceptual vehicle screening, focusing on the medical history, recent changes to key guidelines and guidelines, and the clinical utility of these tests. Dr. Antoni Borrell concluded the session with a presentation on maternal plasma aneuploidy testing for all chromosomes, focusing mainly on cell-free DNA (cfDNA) testing.

Global Perspectives on Self-Administered Abortion

We then had an exciting live panel on “Spreading the Revolution – Why Investing in Self-Administered Abortions is the Way Forward to Realizing Women’s Right to Physical Autonomy”, led by Dr. Dorothy Shaw. The panel started with an introduction by Dr. Bela Ganatra on developing the World Health Organization’s recommendations on medical abortion over the past 20 years.

An exciting conversation followed between Dr. Shaw, Dr. Ganatra, Dr. Laura Gil, Professor Dame Lesley Regan, Mr. Shabin Shrestha and Ms. Jedidah Maina. The discussion focused on the main obstacles to self-directed abortion, namely the over-regulation of medical abortion, criminalization, social stigma and a lack of understanding of the issue.

The speakers shared valuable insights from around the world, used their platform to demand an approach that prioritizes listening to women and trusts them to know how to make decisions about their reproductive life. Speakers highlighted the key role of evidence in lobbying, improving access to information and training, removing barriers to access to safe abortion services, and appreciating the voices of people who have had experiences seeking abortion care.

End the day in Europe

The day ended with the Europe Regional Evening, organized by the European Board and College of Obstetrics and Gynecology (EBCOG), which started with a dedicated panel on the effects of COVID on OBGYN education in the region. We then heard from several speakers about examples of European learning fields. The evening ended with a conversation about OBGYN care for migrants in Europe. Each session of the evening was pleasantly ended with musical interludes by the renowned opera singer Danae Kontora, whose incredible voice could be heard at various points on the night of study.

Recordings of the entire meeting will be available on demand on the virtual congress platform within 24 hours.

To learn more about the congress or to register, visit www.figo2021.org.

Continue Reading

Women’s Health

Program focused on women vets health care could become mandatory for transitioning troops

Published

on

Following a proposal proposed by Congress to ensure women get the information they need about post-military health support services, transition into health care training could become a requirement for women service members leaving their ranks.

“It should be a compulsory program where female veterans can come together and talk about some of their problems in a safe place so that the Department of Defense and their military departments understand what their problems might be,” said Rep. Julia Brownley. D-California, on Tuesday.

“I think one of the problems is that women don’t even know about the program or have access to the program. And certainly, if it is not compulsory, you might miss it completely. “

TIED TOGETHER

Your comments came at a House Veterans Affairs Committee hearing on available support services for female troops and veterans.

As part of the discussion, panel members praised the transition to women’s health training program jointly run by VA and Defense Department officials over the past three years to provide more targeted information on post-military health care and support services.

But despite good reviews of the program so far, the panel’s lawmakers said they felt more needs to be done to promote it to ensure that female veterans are aware of it and have access to training.

Only about 37 percent of all female veterans in America are enrolled in VA health programs, according to a Congressional Research Service report earlier this year. For comparison: around half of all male veterans are enrolled in the system.

Health care officials have said that in transitioning from military life, it is critical to ensure veterans know and understand their available benefits – especially medical care – how to access them, and offer solutions to challenges such as financial problems, mental health issues, and thoughts of suicide .

Only about 1,500 female service workers have completed the Women’s Health Transitioning Training in recent years, which is currently a self-directed online course offered through the Transition Assistance Program. Of this group, 54 percent chose to enroll in VA health care after completing the course.

Lawrencia Pierce, assistant director of VA’s Office for Outreach, Transition and Economic Development, said officials plan to expand the program in the coming months to include virtual instructors to allow for greater engagement and feedback from course participants.

But William Mansell, director of the Defense Support Service Center, said officials hadn’t thought of making the course compulsory for women who are leaving the military because they prefer to keep the transition classes as flexible as possible to allow the transition forces be able to choose the training that best suits them needs.

“There are alternative avenues and different levels of support that allow service members to control their transition processes,” he said. “And if a changing service member states that they need this training, or if their self-assessment indicates that they need it, then they will get it.”

TIED TOGETHER

The Women in Military Service to America Memorial, the only national museum honoring military women, celebrated its 15th anniversary on October 20, 2012.

However, Browley and other lawmakers said this approach may not be strong enough, especially given the preconceived notion that VA health care is more focused on helping men than women.

“When women leave, they need to know what the options are,” she said. “And many of them leave on a traumatic basis. So many women are subjected to harassment or assault that happened to them during their military service. “

There are currently no pending laws on the matter, but Brownley indicated that if the expansion of training progresses slowly, she could begin creating such a plan.

Along with the addition of virtual coaches, Defense and VA officials said they plan to increase funding for the program in the coming months to allow for wider program visibility through existing programs and transition networks.

Leo covers Congress, Veterans Affairs, and the White House for Military Times. He has been reporting on Washington, DC since 2004, focusing on military personnel and veteran politics. His work has received numerous awards, including a 2009 Polk Award, a 2010 National Headliner Award, the IAVA Leadership in Journalism Award, and the VFW News Media Award.

Continue Reading
Advertisement

Trending